GSK Share PerformanceMore
|52 week high||1,724.5 22/06/17|
|52 week low||1,236.5 06/02/18|
|52 week change||-118.0 (-7.29%)|
|4 week volume||189,332,879 01/05/18|
Latest News« previous» nextMore
21/05/2018 - 13:20 StockMarketWire
GlaxoSmithKline said a HIV treatment developed by its ViiV Healthcare joint venture with Pfizer and Shionogi had been ...
21/05/2018 - 11:02 RNS
RNS Number: 7216O GlaxoSmithKline PLC 21 May 2018 Issued: 21 may 2018, London UK - LSE Announcement ViiV Healthcare receives EU marketing authorisation for Juluca (dolutegravir/rilpivirine), the first 2-drug regimen, once-daily, single-pill for the treatment of HIV Juluca maintains viral suppression with two drugs in the smallest single pill regimen Londo...
15/05/2018 - 13:39 RNS
RNS Number: 1568O GlaxoSmithKline PLC 15 May 2018 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Mr P Thomson b) Position/status President, Global Affairs c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participant, ...
11/05/2018 - 15:17 RNS
RNS Number: 8651N GlaxoSmithKline PLC 11 May 2018 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Ms E Walmsley b) Position/status Chief Executive Officer c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participant, a...
10/05/2018 - 17:20 RNS
RNS Number: 7281N GlaxoSmithKline PLC 10 May 2018 BLOCK LISTING SIX MONTHLY RETURN Information provided on this form must be typed or printed electronically and provided to an ris . Date: 10 May 2018 Name of applicant: GlaxoSmithKline plc Name of scheme: GlaxoSmithKline plc 2009 Deferred Annual Bonus Plan Period of return: From: 1 Nove...
09/05/2018 - 17:05 RNS
RNS Number: 5703N GlaxoSmithKline PLC 09 May 2018 GlaxoSmithKline plc (the ' Company ') Transaction notification The following amendments have been made to the 'Director/PDMR Shareholding' announcement released on 26 April 2018 at 15:30 under RNS No 2887M. Dr Jesse Goodman acquired 411.275 notional American Depositary Shares ('ADSs') and not 62...
09/05/2018 - 12:00 RNS
RNS Number: 5226N GlaxoSmithKline PLC 09 May 2018 Issued: Wednesday 9 May 2018, LSE Simon Dingemans, Chief Financial Officer, to retire from GSK GlaxoSmithKline plc (LSE/NYSE: GSK) today announces that Simon Dingemans, Chief Financial Officer (CFO), GSK, has informed the Board of his intention to retire from the Company and to step down fro...
09/05/2018 - 11:03 Interactive Investor
In one of the best months for equity markets in the past decade, Lee Wild reveals which blue chip, AIM and international ...
|Dividend yield||5.333 %|
Latest discussion posts More
“- GlaxoSmithKline is considering a merger or share swap for its Indian consumer products division, in order to avoid a potential 40% tax burden on the sale of its Horlicks ...”▼
“GlaxoSmithKline said a HIV treatment developed by its ViiV Healthcare joint venture with Pfizer and Shionogi had been granted marketing approval by the European Commission. The ...”▼
“Lawsuit alleging dismissal of a whistleblower, not good publicity but doesn't sound like a major issue, given that he "left the company following a reorganisation that resulted ...”▼
Codes & Symbols
|Symbols||GSK, LSE:GSK, GSK.L, GSK:LN, LON:GSK, XLON:GSK|